Roger E. Wyse

Managing Director

Roger E. Wyse joined Burrill in 1998 and has led the development of Burrill & Company’s agriculture, nutraceuticals, health & wellness, and industrial biotechnology related activities in venture capital investing, and merchant banking. Dr Wyse is an internationally recognized scientist and was a Dean at two major research universities, Rutgers and the University of Wisconsin-Madison. Immediately prior to joining Burrill & Company, Dr. Wyse served for five years as Dean of the College of Agricultural and Life Sciences at the University of Wisconsin-Madison. From 1986 to 1992 he served as Dean of Research at Rutgers University. Throughout his administrative career Dr. Wyse has been known for his vision and leadership in developing national policies and funding for life sciences research.

Dr Wyse chairs or serves on the boards of eight private companies (Attune, Brand New Brands, Corazonas, CreAgri, Dreamerz, Efficas, LightFull, and Natural Dentist). He is Co-Chairman of the Malaysian Life Sciences Capital Fund; and is a member of the International Advisory Panel for Biotechnology (BioIAP) for the Prime Minister of Malaysia. He was founder and Chairman of the Alliance for Animal Genome Research.

In research, Dr. Wyse earned international recognition for his basic studies in plant biochemistry. He has published over 150 scientific papers. In recognition of his research accomplishments he received the prestigious Arthur Flemming Award in 1982 as the Outstanding Young Scientist in the US Federal Service. He was elected a Fellow of both the Crop Science Society of America and The American Society of Agronomy. He has also served as a consultant to numerous Fortune 500 companies. Dr. Wyse is sought after as a speaker and advisor on biotechnology: trends, issues, market opportunities, and financing.